Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C
Open Access
- 26 April 2004
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 39 (5) , 1201-1203
- https://doi.org/10.1002/hep.20221
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infectionJournal of Medical Virology, 2004
- Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trialHepatology, 2004
- Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.Gastroenterology, 2003
- Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral loadHepatology, 2003
- Course and outcome of hepatitis CHepatology, 2002
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Sustained Dysfunction of Antiviral CD8+T Lymphocytes after Infection with Hepatitis C VirusJournal of Virology, 2001
- Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter studyHepatology, 2000
- Influence of MHC class II genotype on outcome of infection with hepatitis C virusThe Lancet, 1999